Umar Mehraj
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
Papers in
- Oncology 17
- Cancer-related Molecular Pathways 6
- Cancer Immunotherapy and Biomarkers 4
- Immunology 11
- Immune cells in cancer 4
- Immunotherapy and Immune Responses 4
- Co-authors
- Manzoor Ahmad Mir (33 shared papers)Nissar Ahmad Wani (8 shared papers)Hina Qayoom (11 shared papers)Shariqa Aisha (12 shared papers)Shazia Sofi (10 shared papers)Bashir Ahmad Sheikh (4 shared papers)Abdullah Almilaibary (5 shared papers)Mustfa Alkhanani (4 shared papers)
- Journals
- Medical Oncology (3 papers)Current Pharmaceutical Biotechnology (1 paper)Anti-Cancer Agents in Medicinal Chemistry (1 paper)Frontiers in Pharmacology (1 paper)Applied Biochemistry and Biotechnology (1 paper)
- Partner nations
- IndiaSaudi ArabiaUnited States
In The Last Decade
Umar Mehraj
33 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Oncology 528
- Cancer Research 195
- Immunology 254
- Pulmonary and Respiratory Medicine 221
- Molecular Biology 428
Countries citing papers authored by Umar Mehraj
This map shows the geographic impact of Umar Mehraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umar Mehraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umar Mehraj more than expected).
Fields of papers citing papers by Umar Mehraj
This network shows the impact of papers produced by Umar Mehraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umar Mehraj. The network helps show where Umar Mehraj may publish in the future.
Co-authors
The 25 scholars most cited alongside Umar Mehraj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 199 | |
| 2 | 2021 | 91 | |
| 3 | 2020 | 84 | |
| 4 | 2022 | 76 | |
| 5 | 2021 | 62 | |
| 6 | 2019 | 61 | |
| 7 | 2022 | 60 | |
| 8 | 2022 | 58 | |
| 9 | 2022 | 44 | |
| 10 | 2019 | 43 | |
| 11 | 2019 | 27 | |
| 12 | 2020 | 26 | |
| 13 | 2022 | 25 | |
| 14 | 2022 | 25 | |
| 15 | 2022 | 24 | |
| 16 | 2022 | 24 | |
| 17 | 2022 | 22 | |
| 18 | 2022 | 17 | |
| 19 | 2021 | 16 | |
| 20 | 2021 | 14 |
About Umar Mehraj
Umar Mehraj is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (9 papers), Cancer-related Molecular Pathways (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune cells in cancer (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Oncology (528 citations), Cancer Research (195 citations), Immunology (254 citations), Pulmonary and Respiratory Medicine (221 citations) and Molecular Biology (428 citations). Umar Mehraj has collaborated with scholars based in India, Saudi Arabia and United States. Frequent co-authors include Manzoor Ahmad Mir, Nissar Ahmad Wani, Hina Qayoom, Shariqa Aisha, Shazia Sofi, Bashir Ahmad Sheikh, Abdullah Almilaibary, Mustfa Alkhanani, Basharat Ahmad Bhat and Abid Hamid. Their work appears in journals such as Medical Oncology, Current Pharmaceutical Biotechnology, Anti-Cancer Agents in Medicinal Chemistry, Frontiers in Pharmacology and Applied Biochemistry and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.